Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Mon 24 Apr 2017, 8:00 ASPEN PHARMACARE HOLDINGS LIMITED - Aspens response to the reported Competition Commission investigation
APN 201704240003A
Aspen’s response to the reported Competition Commission investigation

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
and its subsidiaries (collectively “Aspen” or “the Aspen Group”)




ASPEN’S RESPONSE TO THE REPORTED COMPETITION COMMISSION INVESTIGATION

Media reports that the Competition Commission has decided to take up the Democratic Alliance’s
request to investigate the alleged anti-competitive conduct of Aspen in South Africa, in its preliminary
investigation into the pharmaceutical sector, has reference.

Aspen welcomes the process and the opportunity to categorically set aside such allegations of anti-
competitive behavior. Aspen is committed to full and constructive engagement with the Competition
Commission should it wish to pursue such an investigation.

It is worth noting that pharmaceutical prices are approved by the Department of Health in terms of the
Single Exit Price regulatory framework which establishes a universal fixed price for each pharmaceutical
product. Aspen has not increased pricing of its products outside of this regulatory framework.


Durban
24 April 2017

Sponsor:
Investec Bank Limited

Date: 24/04/2017 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: